Minze Flow vs IDENTIFY risk calculator Usage & Stats
The Minze Flow app is used to transfer uroflow measurements from the Minze uroflowmeter towards the central monitoring platform, and asks for direct patient input about his drinking and voiding behavior ("Voiding Diary"). The app can not be used without prescription and supervision of a medical professional.
The app can be used in 2 configurations:
1) HOMEFLOW: Used at the patient's home
Homeflow increases efficiency, enables post treatment follow-up from home and eliminates the stress and discomfort of a uroflow test at the hospital.
Minze Homeflow embodies a bluetooth connected uroflowmeter that fits into a normal toilet. It is connected to the Minze Flow app which allows patients to transfer the data from the uroflowmeter, and to keep a voiding diary of themselves or their child.
2) HOSPIFLOW: Used at the hospital and private practice
Hospiflow is a portable uroflowmeter that can be used on a normal toilet in the hospital and private practice of the urologist. Allowing uroflowtests on a normal toilet reduces stress of a patient in the hospital, leading to more representative uroflow test results
For more information about our services, please visit https://www.minzehealth.com".
DISCLAIMER
Jurisdiction statement: the Minze Flow app is part of a medical device that has been CE certified, FDA listed and TGA approved and shall only be used the following regions:
- United States of America
- all countries in the European Union (EU)
- other countries in the European Economic Area (EEA): Norway, Iceland, Liechtenstein
- Switzerland
- United Kingdom
- Turkey
- Thailand
- Lebanon
- Australia
- Japan
- Kingdom of Saudi Arabia
- Israel
In all other regions, usage is only allowed in the framework of research, clinical investigation or clinical trials.
The Minze Flow app is part of a CE Class 1(m) and FDA listed Class 2 certified medical device (Minze Uroflow System) that has been externally audited. Both safety and accuracy have been certified.
The development of the Minze flow app takes place within the framework of an ISO13485 certified quality management system.
All certificates can be found here:
https://minzehelpcenter.zendesk.com/hc/articles/4405438004370-Regulatory
- Apple App Store
- Free
- Medical
Store Rank
- -
This is an app for clinicians and healthcare professionals to aid in calculating the cancer risk in a patient referred to secondary care with haematuria, without a prior history of urological malignancy.
The app uses patient characteristics, based on the IDENTIFY study conducted by the BURST collaborative group, to calculate the cancer risk. The patient characteristics used to predict the risk are:
Age
Type of haematuria
Sex
Smoking history
Family history of urothelial cancer
Previous benign investigation of haematuria
Urinary tract infection associated with haematuria episode
Catheter use
Previous pelvic radiotherapy
Suprapubic pain or dysuria
Anticoagulation
This app is designed to be a tool for the clinician to aid their decision making in further investigations and the urgency of such investigations in their patients. It should not replace clinical judgment. The calculator also suggests risk categories for the calculated risk, based on less than 1%, 1-5%, 5-20% and more than 20% risk of cancer. These have been chosen by the BURST collaborative group, but may not reflect what the clinician believes to be the correct risk thresholds for each category.
- Apple App Store
- Free
- Medical
Store Rank
- -
Minze Flow VS. 
IDENTIFY risk calculatorJanuary 3, 2025